Raymond Kaiser
He joins the team from Merck Research Laboratories, where he was executive director of bioprocess R&D.
He replaces Carl Martin, who is set to retire after a 35-year career at the firm.
Kaiser said:“I am eager to have the opportunity to work with some of the top minds in the field and apply my decades of biotech development experience to help Covance clients bring new products to market.”